Nutriband Announces Us Patent For AVERSA Abuse-deterrent Technology Utilizing Taste Aversion To Address The Primary Routes Of Abuse Of Opioid-based Transdermal Patches
Portfolio Pulse from Benzinga Newsdesk
Nutriband has announced a US patent for its AVERSA abuse-deterrent technology. The technology uses taste aversion to prevent the abuse of opioid-based transdermal patches.
September 20, 2023 | 11:36 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Nutriband's new patent for AVERSA technology could potentially increase the company's market share in the opioid abuse prevention sector.
The patent for AVERSA technology could give Nutriband a competitive edge in the market for opioid abuse prevention. This could potentially lead to increased sales and revenue, positively impacting the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100